13F filing recap · Q4 2018
What did ArrowMark Partners buy in Q4 2018?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ArrowMark account, including accounts that belong to no fund below.
Stock value
$9.34B
Positions
316
Estimated turnover
18.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
FTDRFrontdoor, Inc.$75.55Mreported value+2.84M sharesSWISolarwinds Corporation$73.12Mreported value+5.29M sharesQDELQuidelortho Corp$65.08Mreported value+1.33M sharesZENZendesk, Inc.$41.74Mreported value+715.1K sharesONOn Semiconductor Corporation$33.23Mreported value+2.01M sharesIARTIntegra Lifesciences Holdings Corp$30.27Mreported value+671.2K sharesCPSCooper-Standard Holdings Inc.$14.06Mreported value+226.4K sharesMODNEURModel N, Inc.$13.72Mreported value+1.04M sharesEFTTechtarget, Inc.$13.05Mreported value+1.07M sharesORTXOrchard Therapeutics Plc$10.11Mreported value+642.7K sharesKODKodiak Sciences Inc.$9.30Mreported value+1.31M sharesRAMPLiveramp Holdings, Inc.$8.60Mreported value+222.6K sharesGILGildan Activewear Inc.$8.50Mreported value+280.0K sharesAIGAmerican International Group, Inc.$6.23Mreported value+158.0K sharesCCMPEURCmc Materials, Inc.$5.05Mreported value+53.0K sharesSAMASchultze Special Purpose Acquisition Corp.$4.98Mreported value+500.0K sharesZAYOZayo Group Holdings, Inc.$4.02Mreported value+176.0K sharesAMCIUAmci Acquisition Corp.$3.98Mreported value+400.0K sharesBOLDEURAudentes Therapeutics Inc$3.70Mreported value+173.4K sharesGHGuardant Health, Inc.$3.65Mreported value+97.1K sharesAPOApollo Global Management, Inc.$3.28Mreported value+133.8K sharesMRNAModerna, Inc.$3.20Mreported value+209.8K sharesTPCOTribune Publishing Company$2.38Mreported value+210.0K sharesBCRXBiocryst Pharmaceuticals, Inc.$1.01Mreported value+125.3K sharesSNAPSnap Inc.$884.0Kreported value+160.5K sharesKRYSKrystal Biotech, Inc.$597.0Kreported value+28.7K sharesATNXEURAthenex, Inc.$254.0Kreported value+20.0K sharesORGOOrganogenesis Holdings Inc.$107.0Kreported value+509.2K shares